Medical Doctor Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Shawna Watson

Orthopaedic Surgery Sandy Springs, GA Medical Doctor

NPI 1073046876 CMS profile 11396085

20 Glenlake Pkwy, Sandy Springs, GA 30328

Open in the dashboard

General payments

$14,583

86 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Shawna Watson of Sandy Springs, GA is reported in the CMS Open Payments database as having received $14,583 across 86 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 75th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,058 11
2024 General $7,246 26
2023 General $3,395 29
2022 General $1,884 20

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Shawna Watson
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Shawna Watson were reported at $2,058. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Shawna Watson Orthopaedic Surgery median Middle half National median
2019 $0 $644 $140–$2,844 $163
2020 $0 $312 $75–$1,860 $114
2021 $0 $520 $117–$2,495 $132
2022 $1,884 $598 $128–$2,731 $149
2023 $3,395 $461 $128–$2,264 $160
2024 $7,246 $497 $134–$2,475 $164
2025 $2,058 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Zimmer Biomet Holdings, Inc. $9,805 38 payments
  2. Stryker Corporation $2,871 29 payments
  3. Onkos Surgical, Inc. $730 7 payments
  4. Davol Inc. $282 2 payments
  5. Total Joint Orthopedics, Inc. $265 1 payment
  6. Vertex Pharmaceuticals Incorporated $156 2 payments
  7. Orthalign Inc $154 1 payment
  8. Aadi Bioscience, Inc. $140 1 payment
  9. IlluminOss Medical, Inc. $102 3 payments
  10. Medical Device Business Services, Inc. $48 1 payment
  11. Other $32 1 payment

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Travel and Lodging $8,327 34 payments
  2. Food and Beverage $5,587 50 payments
  3. Education $669 2 payments
Products named General payments · program years 2022–2025
  1. Avenir $2,262 8 payments
  2. Arcos $1,099 9 payments
  3. Persona $1,049 4 payments
  4. MAKO $893 6 payments
  5. ROSA Knees $865 1 payment
  6. ROSA Hips $865 1 payment
  7. STRYKER NAV3 $837 5 payments
  8. ELEOS LIMB SALVAGE SYSTEM $730 7 payments
  9. OXFORD PARTIAL KNEE $482 1 payment
  10. GMRS $375 4 payments
  11. Other $2,017 33 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 13 drugs

Part D claims

573

Median for Orthopedic Surgery: 203

Drug cost

$5,933

Median for Orthopedic Surgery: $1,433

Branded share of claims

7.5%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 71 $998
Diclofenac Sodium Generic 52 $929
Oxycodone Hcl Generic 88 $781
Gabapentin Generic 90 $652
Mupirocin Generic 54 $615
Doxycycline Monohydrate Generic 41 $473
Meloxicam Generic 58 $367
Tramadol Hcl Generic 41 $294
Cefadroxil Generic 14 $231
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 17 $195

The 10 drugs with the highest cost, of 13 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Fyarro
  • Aadi Bioscience, Inc. $140
$140 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

86 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record